Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Kaya, Serap; Aktas, Bilge; Sismek, Eda; Ozturk, Mehmet; DEDE, FUAT; KAYA, HANDAN; Ugurlu, MUSTAFA; Ozgen, ZERRİN; Koca, Sinan; Halil, Suleyman; Hasanov, Rahib; Alan, Ozkan; Babacan, Nalan; Ercelep, Ozlem; DANE, FAYSAL; GÜMÜŞ, MAHMUT; Yumuk, PERRAN

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Kaya S., Aktas B., Sismek E. T., Ozturk M. A., DEDE F., KAYA H., ...More

JOURNAL OF BUON, vol.22, no.5, pp.1191-1198, 2017 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 22 Issue: 5
Publication Date: 2017
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1191-1198
Keywords: 18F-FDG-PET/CT, hormone-positive, locally advanced breast cancer, neoadjuvant chemotherapy, pathologic complete response, POSITRON-EMISSION-TOMOGRAPHY, SURGICAL ADJUVANT BREAST, NEOADJUVANT CHEMOTHERAPY, PREOPERATIVE CHEMOTHERAPY, EARLY PREDICTION, F-18-FDG PET/CT, SURVIVAL, THERAPY, CYCLOPHOSPHAMIDE, TRASTUZUMAB
Marmara University Affiliated: Yes

Abstract

Purpose: Current evaluation of response to neoadjuvant chemotherapy (NAC) shows that it could achieve pathological complete response (pCR). The purpose of this study was to assess the consistency of maximum uptake values (SUVmax) changes and pCR in hormone-positive locally advanced breast cancer (LABC).